Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the full record of transactions filed by McNulty Alana B., Directrice Commerciale. Director active across 2 companies, notably eFFECTOR Therapeutics, Inc.. Aggregated, 3 disclosures have been published. Activity tracked since 26 June 2024. The latest transaction was disclosed on 26 June 2024 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
Alana B. McNulty is the Chief Business Officer at eFFECTOR Therapeutics, Inc. In this role, she oversees commercial strategies and business development, thereby contributing to the company's growth.